James W. Green - Nov 12, 2021 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role: Chief Executive Officer, Director
Signature: /s/ David Sirois, by power of attorney
Stock symbol: HBIO
Transactions as of: Nov 12, 2021
Transactions value $: $0
Form type: 4
Date filed: 11/15/2021, 03:35 PM
Previous filing: Aug 25, 2021
Next filing: Dec 30, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HBIO	Common Stock	Gift	$0	-13.8K	-0.66%	$0.00	2.08M	Nov 12, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes (a) 218,141 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 194,698 restricted stock units that will vest in three equal installments on December 31, 2021, 2022 and 2023, (c) 163,606 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023, (d) 209,180 remaining restricted stock units that will vest on January 1, 2022 and 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 687,288 shares of common stock beneficially owned by the Reporting Person.

Content

Includes (a) 218,141 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 194,698 restricted stock units that will vest in three equal installments on December 31, 2021, 2022 and 2023, (c) 163,606 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023, (d) 209,180 remaining restricted stock units that will vest on January 1, 2022 and 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 687,288 shares of common stock beneficially owned by the Reporting Person.